Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Global Launch Event for iza-bren Phase III Nasopharyngeal Carcinoma Research Results Successfully Held, Streamed on ESMO Official Website 2025-10-24 16:40
HanchorBio Presents Phase 1 HCB101 Clinical Results at FACO 2025 Demonstrating Safety and Early Antitumor Activity 2025-10-24 07:30
METiS BioTech announces China's First AI-Enabled Formulation Drug Candidate to Complete Phase III Clinical Trial 2025-10-23 21:21
HanchorBio's Novel CD47-SIRPα Therapeutic HCB101 Accepted for Publication in Prestigious Journal of Hematology & Oncology 2025-10-23 19:00
MGI Tech partners with Eva Holding Group to enhance the accuracy of disease monitoring 2025-10-23 11:30
SynbioTech Brings Taiwan's Biotech Excellence to the Global Stage with TWK10® for Muscle Performance and Healthy Aging 2025-10-23 00:00
Visionary Holdings Launches Toronto-Based Joint Venture to Drive Global Commercialization of Innovative Stem Cell Therapy for Diabetes Remission, Targeting a $150 Billion Market Opportunity 2025-10-22 21:30
Blood Publishes Promising Results of IASO Bio's Anti-GPRC5D CAR-T RD118 in Relapsed/Refractory Multiple Myeloma 2025-10-22 19:39
LISCure BioSciences Secures World's First Approval for "Joint Health Probiotic" as Recognized Health Functional Ingredient 2025-10-22 14:28
Renalys Pharma Announces Support for Alport Syndrome Registry Study Organized by Japanese Society for Pediatric Nephrology 2025-10-22 14:00
WuXi Biologics Included in Hang Seng Corporate Sustainability Benchmark Index 2025-10-22 08:30
HanchorBio Secures US Patent for Innovative SIRPα/CD47 Fusion Protein HCB101 2025-10-21 19:00
Google AI Breakthrough Highlights Silmitasertib (CX-4945) as a Novel Pathway in Cancer Immunotherapy 2025-10-21 10:49
SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform 2025-10-21 09:20
Exploring the Next Era of Cell & Gene Therapy with Nobel Laureate in London 2025-10-20 19:43
HanchorBio Showcases Pipeline Momentum with HCB101 and HCB301 Data Across Five Major Oncology Meetings in Q4 2025 2025-10-20 19:00
Groundbreaking Study in the Journal of Clinical Investigation Advances Cell Therapy for Huntington's Disease Treatment 2025-10-20 18:13
Live from ESMO | Hengrui Debuts Exhibition Booth with Landmark Data Showcasing Pharma's Emerging Innovation Power 2025-10-20 14:20
CARsgen Presents Preliminary Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025 2025-10-20 08:15
Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances 2025-10-20 07:00
1 3 4 5 6 7 260